Table 1.
Risk factors for NEC in CHD
| Risk factors | Comment |
|---|---|
| Prematurity | Risk increases with decreasing gestation [10] |
| Low birth weight | Increased risk reported in some but not all studies [6, 12] |
| Associated with poorer outcomes and mortality[12] | |
| Low cardiac output | Episodes of low cardiac output/shock associated with OR 6.5 for NEC[2] |
| Specific diagnoses | Hypoplastic left heart syndrome (incidence 6.1–9%) [5, 11, 12] |
| Duct-dependent lesions – incidence 5% [5] | |
| Truncus arteriosus and aortopulmonary window [2] | |
| Atrioventricular septal defect in VLBW population [1] | |
| Prostaglandin (PGE2) | Longer duration of prostaglandin may be associated with increased risk [6] |
| Higher doses may be associated with increased risk [2] | |
| RACHS-1 Score | Higher score associated with increased risk [5] |
| Associated syndromes | Trisomy 21: association demonstrated in VLBW infants [1] |
| Red Blood Cell Transfusion | Higher rates noted in infants who developed NEC. Causality not established[32] |